|Articles|January 11, 2022
Nitrosamine Control: Understanding the New FDA and EMA Regulations
Author(s)SGS
This technical bulletin discusses major regulatory updates, introduced by the FDA and EMA, regarding nitrosamines and SGS proposed risk assessment method for compliance.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Building the Foundations for Proactive Drug Safety in 2026
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
5